![Men with HIV are more likely to be prescribed dolutegravir than women Men with HIV are more likely to be prescribed dolutegravir than women](https://s3.eu-central-1.amazonaws.com/life4me.plus/uploads/photos/1489157628_58c2bdfc5ccb5.jpeg)
Men with HIV are more likely to be prescribed dolutegravir than women
Women are much less likely to be prescribed the highly-effective HIV antiretroviral, dolutegravir (DTG), than men according to a study published in the Annals of Internal Medicine.
The study, led by Dr Matthew Romo, reviewed the medical records of 134,672 patients from ...
gapprescribingbias2022januarynewsdolutegravirdtggendermanmenwomenguidelinesstudy
![UNAIDS: HIV testing and treatment much lower in men than women UNAIDS: HIV testing and treatment much lower in men than women](https://s3.eu-central-1.amazonaws.com/life4me.plus/uploads/photos/1485762721_588ef0a1ae5a9.jpeg)
UNAIDS: HIV testing and treatment much lower in men than women
According to analysis by UNAIDS, in 2020 testing and treatment targets were almost reached for adult women (aged 15 and above) living with HIV. However, amongst men, these figures were significantly lower.
Compared to women living with HIV, there are 740 000 more men ...
maletargetsknow your status2022unaidsHIVtestingtreatmentmengenderUNHIV-HIV+status
![Moderna starts clinical trial for mRNA based HIV vaccine Moderna starts clinical trial for mRNA based HIV vaccine](https://s3.eu-central-1.amazonaws.com/life4me.plus/uploads/photos/1485761599_588eec3fcca95.jpeg)
Moderna starts clinical trial for mRNA based HIV vaccine
Thursday 27th January 2022, Moderna announced that they have launched their clinical trail of a mRNA-based HIV vaccine - with the first doses being given that same day.
Built on an mRNA (messenger RNA) platform, as used for Moderna’s COVID-19 vaccination, it is hoped ...
2022januaryvaccinemrnamodernabnabbnabsbroadly neutralising antibodiesvaccineshivHIV-HIV+news